These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 7048326)
21. [Cellular blood substitutes]. Z Gesamte Inn Med; 1979 Nov; 34(21):suppl 300-4. PubMed ID: 550615 [No Abstract] [Full Text] [Related]
22. [Granulocyte collection with Heamonetics, its effects on blood donors and efficacy of transfusion]. Iwanaga T; Hasegawa H; Horiuchi A Rinsho Ketsueki; 1978 Oct; 19(10):1447-52. PubMed ID: 739606 [No Abstract] [Full Text] [Related]
23. [Treatment of leukemia relapsed after allogenic bone marrow transplantation with donor lymphocyte infusion: report of 11 cases]. Sanz Rodríguez C; Steegmann JL; Granda A; de la Cámara R; Figuera A; Arranz R; Gómez-García de Soria V; Alegre A; Fernández-Rañada JM Sangre (Barc); 1999 Dec; 44(6):456-63. PubMed ID: 10822760 [TBL] [Abstract][Full Text] [Related]
29. Transfusion requirements of the leukemic patient. Wheeler JT Tex Med; 1981 Aug; 77(8):58-9. PubMed ID: 7268647 [No Abstract] [Full Text] [Related]
30. Supportive care: issues in the use of blood products and treatment of infection. Schiffer CA; Wade JC Semin Oncol; 1987 Dec; 14(4):454-67. PubMed ID: 3122326 [No Abstract] [Full Text] [Related]
31. Myeloablative therapy and bone marrow transplantation in Jehovah's Witnesses with malignancies: single center experience. Mazza P; Prudenzano A; Amurri B; Palazzo G; Pisapia G; Stani L; Pricolo G Bone Marrow Transplant; 2003 Aug; 32(4):433-6. PubMed ID: 12900781 [TBL] [Abstract][Full Text] [Related]
32. Some aspects of recent advances in the use of blood cell components. Schiffer CA Br J Haematol; 1978 Jul; 39(3):289-94. PubMed ID: 359030 [No Abstract] [Full Text] [Related]
33. Quantity and origin of transplanted autologous blood cells are independent factors associated with speed of postransplant hematological reconstitution. Rogulj D; Batinić D; Nemet D; Petrovecki M Croat Med J; 1999 Sep; 40(3):404-8. PubMed ID: 10411969 [TBL] [Abstract][Full Text] [Related]
34. Granulocyte transfusions from G-CSF-stimulated donors for the treatment of severe infections in neutropenic pediatric patients with onco-hematological diseases. Cesaro S; Chinello P; De Silvestro G; Marson P; Picco G; Varotto S; Pittalis S; Zanesco L Support Care Cancer; 2003 Feb; 11(2):101-6. PubMed ID: 12560938 [TBL] [Abstract][Full Text] [Related]
35. [Stability of blood cell preparations for malignant blood diseases]. Kekomäki R Duodecim; 1989; 105(11):1138-47. PubMed ID: 2666096 [No Abstract] [Full Text] [Related]
36. G-CSF-mobilised granulocyte transfusion to an ALL patient complicated by cytomegalovirus transmission. Meyer-Koenig U; Hufert FT; Duffner U; Neumann-Haefelin D; Henschen M Bone Marrow Transplant; 2004 Dec; 34(12):1095-6. PubMed ID: 15502855 [No Abstract] [Full Text] [Related]
37. [Clinical data on the efficiency of thrombocyte and granulocyte transfusion in acute leukemia]. Kamanabroo D; Büchner T; Urbanitz D; Balleisen L; van de Loo J Med Welt; 1982 Dec; 33(51-52):1861-3. PubMed ID: 7162407 [No Abstract] [Full Text] [Related]